Table 1 Change in tear eosinophil cationic protein (ECP) (µg/l).
| ECP tear concentrations (µg/l) | ||||
|---|---|---|---|---|
| Visits | NAAGA (n = 10*) | LEVO (n = 10*) | ||
| Mean (SD) | Median (quartiles) | Mean (SD) | Median (quartiles) | |
| D0 | 1152.6 (654.0) | 1175.0 (700.0; 1600.0) | 1120.8 (1868.1) | 47.6 (8.6; 2310.0) |
| D7 | 692.6 (954.2) | 383.6 (170.0; 765.0) | 1381.1 (1864.5) | 161.0 (35.8; 2465.0) |
| D28 | 329.9 (324.5) | 230.0 (62.0; 590.0) | 1468.8 (2171.3) | 116.0 (20.6; 2655.0) |
| Treatment effect† estimate; 95% CI | p value† | |||
|---|---|---|---|---|
| D7–D0 | −806.5 (−1302.1; 4.4) | 0.050 | ||
| D28–D0 | −750.5 (−1270.0; −14.3) | 0.046 | ||
| Both visits–D0 | −911.7 (−1426.0; −269.9) | 0.023 |
*Naaga group: day 0 n = 10, day 7 n = 9 and day 28 n = 8. Levo group: day 0 n = 10; day 7 n = 9 and day 28 n = 9; †Hodges–Lehmann semiparametric estimate and Wilcoxon test p value.